Immunotherapy for SARS-CoV-2: potential opportunities

被引:37
作者
Pashaei, Mehrnoosh [1 ]
Rezaei, Nima [1 ,2 ,3 ]
机构
[1] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran
[2] Univ Sci Educ & Res Network USERN, Network Immun Infect Malignancy & Autoimmun NIIIM, Tehran, Iran
[3] Univ Tehran Med Sci, Res Ctr Immunodeficiencies, Childrens Med Ctr, Tehran, Iran
关键词
Immunotherapy; monoclonal antibodies; severe acute respiratory syndrome coronavirus 2; COVID-19; ACUTE RESPIRATORY SYNDROME; CORONAVIRUS; THERAPY; SPIKE;
D O I
10.1080/14712598.2020.1807933
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1111 / 1115
页数:5
相关论文
共 40 条
[1]   COVID-19 and lung cancer: risks, mechanisms and treatment interactions [J].
Addeo, Alfredo ;
Obeid, Michel ;
Friedlaender, Alex .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
[2]   Clinical use of Convalescent Plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities [J].
Al-Riyami, Arwa Z. ;
Schafer, Richard ;
van den Berg, Karin ;
Bloch, Evan M. ;
Estcourt, Lise J. ;
Goel, Ruchika ;
Hindawi, Salwa ;
Josephson, Cassandra D. ;
Land, Kevin ;
McQuilten, Zoe K. ;
Spitalnik, Steven L. ;
Wood, Erica M. ;
Devine, Dana, V ;
So-Osman, Cynthia .
VOX SANGUINIS, 2021, 116 (01) :88-98
[3]   The possible of immunotherapy for COVID-19: A systematic review [J].
AminJafari, Akram ;
Ghasemi, Sorayya .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 83
[4]  
Bao L, 2020, bioRxiv, DOI 10.1101/2020.03.13.990226
[5]  
Bian, 2020, MEPLAZUMAB TREATS CO, DOI 10.1101/2020.03.21.20040691
[6]   Progress and Challenges in the Use of MAP1LC3 as a Legitimate Marker for Measuring Dynamic Autophagy In Vivo [J].
Bonam, Srinivasa Reddy ;
Bayry, Jagadeesh ;
Tschan, Mario P. ;
Muller, Sylviane .
CELLS, 2020, 9 (05)
[7]   Commensal-Pathogen Interactions along the Human Nasal Passages [J].
Brugger, Silvio D. ;
Bomar, Lindsey ;
Lemon, Katherine P. .
PLOS PATHOGENS, 2016, 12 (07)
[8]   Coupling anammox with heterotrophic denitrification for enhanced nitrogen removal: A review [J].
Cao, Shenbin ;
Du, Rui ;
Zhou, Yan .
CRITICAL REVIEWS IN ENVIRONMENTAL SCIENCE AND TECHNOLOGY, 2021, 51 (19) :2260-2293
[9]   Effectiveness of convalescent plasma therapy in severe COVID-19 patients [J].
Duan, Kai ;
Liu, Bende ;
Li, Cesheng ;
Zhang, Huajun ;
Yu, Ting ;
Qu, Jieming ;
Zhou, Min ;
Chen, Li ;
Meng, Shengli ;
Hu, Yong ;
Peng, Cheng ;
Yuan, Mingchao ;
Huang, Jinyan ;
Wang, Zejun ;
Yu, Jianhong ;
Gao, Xiaoxiao ;
Wang, Dan ;
Yu, Xiaoqi ;
Li, Li ;
Zhang, Jiayou ;
Wu, Xiao ;
Li, Bei ;
Xu, Yanping ;
Chen, Wei ;
Peng, Yan ;
Hu, Yeqin ;
Lin, Lianzhen ;
Liu, Xuefei ;
Huang, Shihe ;
Zhou, Zhijun ;
Zhang, Lianghao ;
Wang, Yue ;
Zhang, Zhi ;
Deng, Kun ;
Xia, Zhiwu ;
Gong, Qin ;
Zhang, Wei ;
Zheng, Xiaobei ;
Liu, Ying ;
Yang, Huichuan ;
Zhou, Dongbo ;
Yu, Ding ;
Hou, Jifeng ;
Shi, Zhengli ;
Chen, Saijuan ;
Chen, Zhu ;
Zhang, Xinxin ;
Yang, Xiaoming .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (17) :9490-9496
[10]   Mesenchymal Stem Cell Therapy for COVID-19: Present or Future [J].
Golchin, Ali ;
Seyedjafari, Ehsan ;
Ardeshirylajimi, Abdolreza .
STEM CELL REVIEWS AND REPORTS, 2020, 16 (03) :427-433